• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夏枯草多糖对甲状腺相关眼病患者体外培养的眼外肌成纤维细胞的作用。

Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.

机构信息

Department of Ophthalmology, Chengdu Integrated TCM & Western Medicine Hospital/ Chengdu First People's Hospital, Chengdu, 610041, Sichuan Province, China.

Key Laboratory of Standardization of Chinese Medicine, Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, Sichuan Province, China.

出版信息

Exp Eye Res. 2020 Dec;201:108276. doi: 10.1016/j.exer.2020.108276. Epub 2020 Sep 28.

DOI:10.1016/j.exer.2020.108276
PMID:32991886
Abstract

To observe the effect of Prunella vulgaris polysaccharides (PVP) on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy (TAO). PVP at different concentrations were used to treat different groups of fibroblasts from TAO patients and normal persons. Dexamethasone (Dex) was used as a positive control drug, and interferon-γ (IFN-γ) was used as a positive stimulant. The effects of PVP on the proliferation of orbital fibroblasts, the secretion of hyaluronic acid (HA), the expression of intercellular adhesion molecule-1 (ICAM-1/CD54) and apoptosis in orbital fibroblasts were determined. The experimental results showed when the concentration of PVP was greater than 400 μg/mL, it could significantly inhibit the proliferation of orbital fibroblasts from patients with TAO (P < 0.05). However, no definite inhibitory effect was observed in the orbital fibroblasts from the normal people. Dex could significantly inhibit the proliferation of orbital fibroblasts from patients with TAO and the normal people (P < 0.05). In contrast, every concentration of IFN-γ could promote the orbital fibroblasts from patients with TAO and the normal people proliferation. No groups had statistically significant stimulatory effect on HA secretion by orbital fibroblasts from normal people (P > 0.05). But the Dex group, IFN-γ+PVP-1600 group and IFN-γ+Dex group could significantly inhibit the secretion of HA from orbital fibroblasts of TAO patients. And there were no groups had statistically significant stimulatory effect on the expression of ICAM-1/CD54 in orbital fibroblasts from TAO patients (P > 0.05). PVP and Dex at all concentrations could significantly promote orbital fibroblast co-cultured with IFN-γ apoptosis (P < 0.05). But without IFN-γ, PVP and Dex at all concentrations could only significantly promote orbital fibroblast from TAO patients apoptosis (P < 0.05). These results suggest that PVP exerts its therapeutic effect by inhibiting the proliferation of orbital fibroblasts and promoting the apoptosis of orbital fibroblasts in TAO patients. In addition, in this process, HA secretion is suppressed. But the participation of IFN-γ is required. This effect is similar to that of Dex. And in the MTT experiment, the efficacy of PVP showed selectivity for TAO patients. This is different from Dex. This may be a feature of PVP that deserves attention.

摘要

观察夏枯草多糖(PVP)对甲状腺相关眼病(TAO)患者体外培养的眼眶成纤维细胞的作用。用不同浓度的 PVP 处理 TAO 患者和正常人的不同眼眶成纤维细胞组。地塞米松(Dex)作为阳性对照药物,干扰素-γ(IFN-γ)作为阳性刺激物。测定 PVP 对眼眶成纤维细胞增殖、透明质酸(HA)分泌、细胞间黏附分子-1(ICAM-1/CD54)表达及眼眶成纤维细胞凋亡的影响。实验结果表明,当 PVP 浓度大于 400μg/ml 时,可明显抑制 TAO 患者眼眶成纤维细胞的增殖(P<0.05)。但正常人眼眶成纤维细胞未见明显抑制作用。Dex 可明显抑制 TAO 患者和正常人眼眶成纤维细胞的增殖(P<0.05)。相反,IFN-γ 的每个浓度均可促进 TAO 患者和正常人眼眶成纤维细胞的增殖。各组对正常人眼眶成纤维细胞 HA 分泌均无统计学显著刺激作用(P>0.05)。但 Dex 组、IFN-γ+PVP-1600 组和 IFN-γ+Dex 组可明显抑制 TAO 患者眼眶成纤维细胞 HA 的分泌。各组对 TAO 患者眼眶成纤维细胞 ICAM-1/CD54 表达均无统计学显著刺激作用(P>0.05)。PVP 和 Dex 各浓度均可明显促进与 IFN-γ 共培养的眼眶成纤维细胞凋亡(P<0.05)。但无 IFN-γ 时,PVP 和 Dex 各浓度仅可明显促进 TAO 患者眼眶成纤维细胞凋亡(P<0.05)。这些结果提示 PVP 通过抑制 TAO 患者眼眶成纤维细胞的增殖和促进其凋亡发挥治疗作用。此外,在此过程中抑制 HA 的分泌。但需要 IFN-γ 的参与。这种作用类似于 Dex。并且在 MTT 实验中,PVP 的疗效对 TAO 患者表现出选择性。这与 Dex 不同。这可能是 PVP 值得关注的一个特点。

相似文献

1
Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.夏枯草多糖对甲状腺相关眼病患者体外培养的眼外肌成纤维细胞的作用。
Exp Eye Res. 2020 Dec;201:108276. doi: 10.1016/j.exer.2020.108276. Epub 2020 Sep 28.
2
[Effect of dexamethasone on expression of intercellular adhesion molecule-1 in orbital fibroblasts from thyroid associated ophthalmopathy].[地塞米松对甲状腺相关性眼病眼眶成纤维细胞细胞间黏附分子-1表达的影响]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jan;38(1):113-5.
3
Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.透明质酸通过CD44诱导甲状腺相关性眼病患者眼眶成纤维细胞中COX-2的表达。
Invest Ophthalmol Vis Sci. 2014 Oct 23;55(11):7441-50. doi: 10.1167/iovs.14-14873.
4
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.棕榈酸酯诱导甲状腺相关眼病患者来源的眼眶成纤维细胞分泌白细胞介素-6和单核细胞趋化蛋白-1。
Mol Vis. 2012;18:1467-77. Epub 2012 Jun 4.
5
MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.微小RNA-21促进甲状腺相关性眼病眼眶成纤维细胞的纤维化。
Mol Vis. 2015 Mar 30;21:324-34. eCollection 2015.
6
Benzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition.苄叉丙酮衍生物通过抑制 STAT-1 减少甲状腺相关眼病患者眼眶成纤维细胞 IFN-γ 诱导的 IP-10/CXCL10 产生。
Exp Mol Med. 2014 Jun 13;46(6):e100. doi: 10.1038/emm.2014.26.
7
[Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].[胰岛素样生长因子-1受体对甲状腺相关眼病眼眶成纤维细胞透明质酸合成的影响及其机制]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Sep;48(5):727-731.
8
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.甲状腺相关性眼病患者的眼眶成纤维细胞过度表达CD40:CD154可超诱导白细胞介素-6、白细胞介素-8和单核细胞趋化蛋白-1。
Invest Ophthalmol Vis Sci. 2009 May;50(5):2262-8. doi: 10.1167/iovs.08-2328. Epub 2008 Dec 30.
9
[The study of CD90 expressing in orbital fibroblasts of thyroid associated ophthalmopathy].[CD90在甲状腺相关眼病眼眶成纤维细胞中的表达研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Nov;37(6):879-81.
10
Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.局部眼眶免疫的新认识:Th17 细胞通路在甲状腺相关性眼病中的作用。
J Clin Endocrinol Metab. 2019 May 1;104(5):1697-1711. doi: 10.1210/jc.2018-01626.

引用本文的文献

1
Efficacy and safety of L. combined with antithyroid drugs for hyperthyroidism: a systematic review and meta-analysis.左旋甲状腺素联合抗甲状腺药物治疗甲状腺功能亢进症的疗效与安全性:一项系统评价和荟萃分析
Front Pharmacol. 2025 Feb 27;16:1530152. doi: 10.3389/fphar.2025.1530152. eCollection 2025.
2
Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis.桥本甲状腺炎的临床比较疗效及治疗策略:一项系统评价与网状Meta分析
Heliyon. 2024 Jul 31;10(16):e35114. doi: 10.1016/j.heliyon.2024.e35114. eCollection 2024 Aug 30.
3
Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy.
基于格雷夫斯眼病发病机制的现有及有前景的治疗方法。
Front Pharmacol. 2023 Nov 16;14:1217253. doi: 10.3389/fphar.2023.1217253. eCollection 2023.
4
Roles of four targets in the pathogenesis of graves' orbitopathy.四个靶点在格雷夫斯眼眶病发病机制中的作用。
Heliyon. 2023 Aug 29;9(9):e19250. doi: 10.1016/j.heliyon.2023.e19250. eCollection 2023 Sep.
5
L.: An Updated Overview of Botany, Chemical Composition, Extraction Methods, and Biological Activities.L.:植物学、化学成分、提取方法及生物活性的最新综述。
Pharmaceuticals (Basel). 2023 Aug 4;16(8):1106. doi: 10.3390/ph16081106.
6
Research progress in Th17 cells and the relevant cytokines in Graves ophthalmopathy.格雷夫斯眼病中 Th17 细胞及相关细胞因子的研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1748-1753. doi: 10.11817/j.issn.1672-7347.2022.220205.
7
Emerging therapeutic role of in thyroid disease.[此处原文不完整,缺少具体物质或疗法名称]在甲状腺疾病中的新兴治疗作用。
Chin Herb Med. 2022 May 24;14(3):403-413. doi: 10.1016/j.chmed.2021.12.005. eCollection 2022 Jul.